FGF23 and myeloid sarcoma: The primary aim of this study is to further elucidate the vitamin D-FGF23 axis by measuring multiple D metabolites and FGF23 using accurate state-of-the art analytical methods in a well-defined cohort of MS patients and healthy controls.